Range [Axis]
Minimum [Member]
Property, Plant and Equipment, Type [Axis]
Computers and software [Member]
Maximum [Member]
Office furniture and equipment [Member]
Leasehold improvements [Member]
Equity Components [Axis]
Retained Earnings [Member]
Capital Units [Member]
Additional Paid-in Capital [Member]
Software Development [Member]
Furniture and Fixtures [Member]
Leasehold Improvements [Member]
Investment Sector [Axis]
Rail Vision Ltd [Member]
Consolidated Entities [Axis]
Parent Company [Member]
Related Party [Axis]
Senior Officers Options [Member]
Chief Operating Officer Options [Member]
Warrant A [Member]
Intermediator [Member]
Warrants E [Member]
Warrant [Member]
Management Consulting Service [Member]
Chief Financial Officer Options [Member]
Three Members Of Board Of Directors Options [Member]
Two Service Providers Options [Member]
Several Service Providers Options [Member]
Chief Executive Officer Options [Member]
Magnas Employees Options [Member]
Four Members Of Board Of Directors Options [Member]
Employees Options [Member]
Sale of Stock [Axis]
Private Placement [Member]
Warrants F [Member]
Warrants F 1 [Member]
Warrants G [Member]
Option Indexed to Issuer's Equity, Type [Axis]
Employee Stock Option [Member]
Warrant B [Member]
Award Date [Axis]
Issuance Date [Member]
Issuance Date One [Member]
Issuance Date Two [Member]
Issuance Date Three [Member]
Issuance Date Four [Member]
Income Statement Location [Axis]
Research and Development Expense [Member]
Selling and Marketing Expense [Member]
General and Administrative Expense [Member]
Warrant 1 [Member]
Warrant 2 [Member]
Warrant 3 [Member]
Warrant Investment [Member]
Type Of Currency [Axis]
NIS [Member]
Several Service Providers Options One [Member]
Service Providers Options [Member]
Service Providers Options One [Member]
Board of Directors Chairman [Member]
Marketing and Sales [Member]
General and Administrative [Member]
General and Administrative Expense One [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Warrants B and F [Member]
Warrants B [Member]
RH Electronics Ltd [Member]
Magna [Member]
Document and Entity Information [Abstract]
Entity Registrant Name
Entity Central Index Key
Trading Symbol
Amendment Flag
Current Fiscal Year End Date
Document Type
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Entity Emerging Growth Company
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Filer Category
Entity Ex Transition Period
Entity Shell Company
Entity Common Stock, Shares Outstanding
Statement of Financial Position [Abstract]
ASSETS
Current assets
Cash and cash equivalents
Short Term Deposits
Marketable equity securities
Other investments
Other current receivables
Total current assets
Non-current assets
Investment in affiliated company
Other investments
Fixed assets, net
Total non-current assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Trade payables
Other current payables
Total current liabilities
Derivative warrant liabilities
TOTAL LIABILITIES
Shareholders' equity
Ordinary shares, NIS 0 par value; Authorized 1,000,000,000 shares; Issued and outstanding: 131,935,404 and 109,502,289 shares as of December 31, 2018, December 31, 2017 respectively
Additional paid in capital
Accumulated deficit
Total shareholders' equity
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Research and development expenses, net
Marketing and sales
General and administrative
Operating loss
Equity in net loss (gain) of an affiliated company
Financial expenses (income), net
Net Loss
Basic and diluted loss per share (in USD)
Weighted average number of shares outstanding used in computing basic and diluted loss per share - in thousands
Statement [Table]
Statement [Line Items]
Share Capital
Additional paid in capital
Accumulated Deficit
Beginning Balance
Beginning Balance, shares
CHANGES
Deemed contribution from Magna
Issuance of ordinary shares to effect reverse recapitalization transaction
Issuance of ordinary shares to effect reverse recapitalization transaction, shares
Issuance of ordinary shares and warrants
Issuance of ordinary shares and warrants, shares
Exercise of warrants
Exercise of warrants, shares
Exercise of options
Exercise of options, shares
Share-based payment
Share-based payment, shares
Loss for the year
Ending Balance
Ending Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities
Adjustments to reconcile loss to net cash used in operating activities:
Net cash used in operating activities
Cash Flows from Investing Activities
Sales of marketable securities
Changes in short term deposits
Investment in affiliated company
Purchase of fixed assets
Net cash used in investing activities
Cash flows from Financing Activities:
Issuance of ordinary shares and warrants, net of issuance expenses
Proceeds from exercise of Warrants
Proceeds from exercise of Options
Acquisition of a subsidiary in connection with reverse recapitalization (See below)
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Increase (Decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the period
Cash and cash equivalents at the end of the period
Adjustments to reconcile loss to net cash used in operating activities:
Share-based payment
Depreciation
Revaluation of derivative warrant liabilities
Equity in loss (gain) of an affiliated company
Revaluation of other investments
Revaluation of securities classified as trading
Realized loss of securities classified as available-for-sale, net
Issuance expenses presented in financing activities
Exchange rate changes on cash and cash equivalents
Changes in assets and liabilities:
Decrease (Increase) in other current assets
Increase in trade payables
Decrease in other payables
Adjustments to reconcile loss to net cash used in operating activities
Supplemental information for Cash Flow:
Assets (liabilities) acquired:
Current assets and liabilities excluding cash and cash equivalents
Marketable equity securities
Fixed assets
Other current assets
Reverse recapitalization effect on equity
Cash acquired in connection reverse recapitalization
Non Cash Activities:
Exercise of Warrant investment (see note 4C2)
General [Abstract]
GENERAL
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
OTHER CURRENT RECEIVABLES
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENT IN AFFILIATE COMPANY
Property, Plant and Equipment [Abstract]
FIXED ASSETS, NET
Retirement Benefits [Abstract]
EMPLOYEE RIGHTS UPON RETIREMENT
Payables and Accruals [Abstract]
OTHER CURRENT PAYABLES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES LIABILITIES
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE WARRANTS LIABILITIES
Equity [Abstract]
SHAREHOLDERS' EQUITY
Research and Development [Abstract]
RESEARCH AND DEVELOMENT, NET
Marketing and Sales [Abstract]
MARKETING AND SALES
General and Administrative [Abstract]
GENERAL AND ADMINISTRATIVE
Financial Expense (Income) Net [Abstract]
FINANCIAL EXPENSE (INCOME) NET
Income Tax Disclosure [Abstract]
TAXES ON INCOME
Related Party Transactions [Abstract]
TRANSACTIONS AND BALANCES WITH INTERESTED AND RELATED PARTIES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Use of estimates in the preparation of financial statements
Financial statement in U.S. dollars
Cash and cash equivalents
Property and equipment
Fair value of financial instruments
Marketable equity securities
Investment in Affiliate Company
Share-based compensation
Basic and diluted net loss per share
Research and development expenses, net
Reclassification
Recent Accounting Standards
Schedule of property and equipment
Summary of basic and diluted per share and per ADS
Schedule of other current receivables
Schedule of investment in affiliate of activity
Schedule of investment in affiliate of balance sheet data
Schedule of investment in affiliate of operating data
Schedule of investment in a warrants investment
Schedule of fixed assets, net
Schedule of other current payables
Schedule of future minimum lease payment for operating lease
Summary of weighted average of inputs
Summary of outstanding and exercisable
Summary of liabilities measured on recurring basis
Summary of fair value of options granted
Summary of option activity
Summary of share-based compensation expense
Schedule of research and develoment, net
Schedule of marketing and sales
Schedule of general and administrative
Schedule of financial expense income net
Schedule of deferred tax assets
Schedule of related party transactions
General (Textual)
Percentage of acquisition transaction
Ordinary shares issued
Ordinary shares issued, percentage
Acquisition transaction, description
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Property and equipment estimated useful lives of assets
Net Loss
Basic and diluted loss per ADS (in USD)
Weighted average number of shares outstanding used in computing basic and diluted loss per share
Weighted average number of ADS outstanding used in computing basic and diluted loss per ADS
Governmental institutes
Prepaid expenses
Other receivables
Other current receivables
Investment in affiliate company, Beginning Balance
Exercise of Warrant investment
Gain from Issuance of shares to third party
Equity in net loss of affiliated company
Investment in affiliate company, Ending Balance
Balance sheet data:
Current assets
Long-term assets
Current liabilities
Equity
Operating data:
Revenue
Operating loss
Net loss
Investment in a warrants investment, Beginning Balance
Warrants exercised (see note 4C2)
Revaluation (see note 4C1)
Investment in a warrants investment, Ending Balance
Investment Holdings [Table]
Summary of Investment Holdings [Line Items]
Investment in Affiliated Company (Textual)
Description of share purchase agreement
Number of installments
Maximum aggregate investment amounts
Investment amounts
Equity method investment, percentage
Purchased ordinary shares
Price per share
Warrants shares
Other investments amount
Investment in affiliate amount
Percentage of diluted basis
Private placements gross amount
Equity in net loss (gain) of an affiliated company
Exercised warrants to purchase ordinary shares
Operations of financial income
Aggregate contribution on Warrant
Aggregate contribution paid in cash
Fair value of the exercised warrants
Computers and Software [Member]
Office furniture and equipment
Leasehold improvements [Member]
Cost:
Fixed Assets, Gross
Less - accumulated depreciation
Fixed Assets, Net
Fixed Assets, Net (Textual)
Employee Rights Upon Retirement (Textual)
Retirement benefits, description
Employees and related expenses
Accrued expenses
Other payables
Other current payables
Future minimum lease payment for operating lease
2019
2020
2021
Total
Schedule of Related Party Transactions, by Related Party [Table]
Related Party Transaction [Line Items]
TypeOfCurrencyAxis [Axis]
Commitments and Contingencies Liabilities (Textual)
Research and development expenses
Royalty, description
Grants obtained amount
Monthly lease payment
Lease agreement, description
Operating leases expire date
Weighted average of inputs
Share price
Exercise price
Expected volatility
Risk-free interest
Dividend yield
Expected life of up to (years)
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Series A (Mar-2016) (10B(a)) [Member]
Series B (Mar-2016) (10B(a)) [Member]
Series A (May-2016) (10B(b)) [Member]
Series B (May-2016) (10B(b)) [Member]
Series E (Oct-2016) (10B(c)) [Member]
Outstanding and Exercisable
Exercise Price Per Share
Exercisable Through
Series A (Mar-2016) [Member]
Series B (Mar-2016) [Member]
Series A (May-2016) [Member]
Series B (May-2016) [Member]
Series E (Oct-2016) [Member]
Shares outstanding, Beginning
Exercised
Revaluation of warrants
Shares outstanding, Ending
Derivative Warrants Liabilities (Textual)
Fair value assumptions, description
Exercise price
Expected volatility
Risk-free interest
Expected life of up to (years)
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Number of Options, Outstanding beginning balance
Number of Options, Granted
Number of Options, Exercised
Number of Options, Forfeited
Number of Options, Outstanding ending balance
Number of Options, Exercisable
Weighted Average Exercise Price, Outstanding beginning balance
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited
Weighted Average Exercise Price, Outstanding ending balance
Weighted Average Exercise Price, Exercisable
Weighted Average remaining contractual term, Outstanding
Weighted Average remaining contractual term, Exercisable
Total share-based compensation expense
Issuance of ordinary shares
Ordinary shares price
Warrant exercise price
Exercisable contractual term
Issuance expenses, net
Proceeds from issuance of warrants
Shares granted to service provider, value
Shares granted to service provider, shares
Weighted average volatility
Dividend yields
Weighted average life of options
Options grants, shares
Options vesting term
Warrants exercised
Total unrecognized compensation cost
Weighted-average period
General and administrative expenses
Fair value of warrants liabilities
Net of issuance expenses
Warrants to purchase ordinary share
Outstanding balance of warrants
Payroll and related expenses
Subcontracted work and consulting
Share based payments to service provider
Rent and office maintenance
Travel expenses
Other
Sales of prototypes
Research and development total
Research and Develoment [Member]
Research and Develoment, Net (Textual)
Share-based payment
Payroll and related expenses
Exhibitions, conventions and travel expenses
Consultants
Other
Total marketing and sales
Marketing and Sales (Textual)
Payroll and related expenses
Share-based payments to service providers
Professional services
Directors fees and insurance
Travel expenses
Rent and office maintenance
Consultation fees to a related party
Other
Total general and administrative
General and Administrative (Textual)
Revaluation of securities, net
Revaluation of other investments
Revaluation of derivative warrants
Exchange rate differences
Other
Financial expense income net total
Deferred tax assets:
Operating loss carryforward
Deferred taxes due to carryforward losses
Deferred tax assets gross
Valuation allowance
Net deferred tax asset
Taxes on Income (Textual)
Israeli corporate tax rates
Corporate tax rates, description
Commission paid to former controlling shareholder
Subcontracted work and consulting
Share-Based payments to service provider
Total
Other accounts payable
Balance total
Subsequent Event [Table]
Subsequent Event [Line Items]
Subsequent Events (Textual)
Business agreement, description
Issuance of ordinary shares
Ordinary price per share
Post investment valuation
Issued and outstanding share capital, Percentage
Warrants to purchase of ordinary shares
Transaction date
Related party transaction, description
Issuance of ordinary shares value
Warrants to purchase of ordinary shares, description
Warrants expiration date
Exercise price of warrants
Public offering of ADSs
Additional public offering of ADSs
Cash acquired in connection reverse recapitalization.
Class of warrant exercised during the period.
The amount of commission paid to former controlling shareholder.
Total amount of expenses for consultants fees.
Total amount of consultation fees to a related party.
Current assets and liabilities excluding cash and cash equivalents.
Deemed contribution from magna.
Description of share purchase agreement.
The amount of directors fee and insurance expense.
Disclosure of financial expense income net.
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share in american depository shares (ADS) are the same amount and reported as a single line item on the face of the financial statements.
Equity changes,
The amount of exchange rate differences.
Exercised warrants to purchase ordinary shares.
Expenses incurred for exhibitions, conventions and travel expenses.
It represents financial expense income net disclosure.
The amount for fixed assets.
The entire disclosure for general and administrative.
Disclosure of general information.
Investment in affiliate company textual.
Investment in affiliate cost.
Issuance expenses presented in financing activities.
Marketable equity securities
The entire disclosure for marketing and sales.
Number of installments.
Other current assets.
The amount of other financial expense (income) net.
Total amount of expenses related to other marketing and sales expenses.
The amount of other research and development expenses.
Total amount of Payroll,general and administrative related expenses.
Total amount of expenses related to marketing and sales.
The amount of payroll research and development related expenses for the reporting period.
Percentage of diluted basis.
Purchased shares of ordinary shares.
The amount of rent and office maintenance for research and development.
The amount of revaluation of derivative warrants	.
The amount of revaluation of other investments.
The amount of finance expense income net.
Reverse recapitalization effect on equity.
Description of the royalty payments.
Tabular disclosure of general and administrative.
Tabular disclosure of data and information required in the supplementary schedule applicable to management companies affiliated investments on Activity
Tabular disclosure of data and information required in the supplementary schedule applicable to management companies affiliated investments on Balance sheet data.
Tabular disclosure of data and information required in the supplementary schedule applicable to management companies affiliated investments on Operating data
Tabular disclosure of marketing and sales.
Tabular disclosure of research and development.
Revaluation of warrants.
The amount of share-Based payments to service provider.
The amount of share based payments to service provider for research and development expenses.
Total amount of share-based payments to service providers for general and administrative expenses.
Stock issued during period shares exercise of warrants.
Stock issued during period value exercise of warrants.
The amount of subcontracted work and consulting.
The fee payment of subcontracted work and consulting for thr reporting period.
The amount of transactions and balances with interested and related parties.
The amount of travel expenses related to research and development.
Average number of shares or units issued and outstanding that are used in calculating basic and diluted american depository shares (ADS).
Fair Value Assumptions and Methodology for Assets and Liabilities.
Agreed upon price for the exchange of the underlying asset.
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.
Risk-free interest rate assumption used in valuing an instrument.
Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).
Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
The tabular disclosure of investment in a warrants investment.
The amount of exercise of Warrant investment .
The number of outstanding balance of warrants.
Amount of sales of prototypes.
Amount of post investment valuation.
Aggregate warrants to purchase of ordinary shares.
Amount of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
Assets, Current
Other Long-term Investments
Assets, Noncurrent
Assets
Liabilities, Current
Liabilities
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Operating Income (Loss)
Nonoperating Income (Expense)
Shares, Outstanding
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities
Net Cash Provided by (Used in) Operating Activities
Payments for (Proceeds from) Short-term Investments
Payments for (Proceeds from) Investments
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Payments to Acquire Businesses, Gross
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Share-based Compensation
Gain (Loss) on Sale of Equity Investments
Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
Increase (Decrease) in Other Current Assets
Marketable Equity Securities
ExerciseOfWarrantInvestments
Cash and Cash Equivalents, Policy [Policy Text Block]
Marketable Securities, Policy [Policy Text Block]
Research and Development Expense, Policy [Policy Text Block]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures
Equity Method Investment, Summarized Financial Information, Current Assets
Equity Method Investment, Summarized Financial Information, Current Liabilities
Operating Leases, Future Minimum Payments Due
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
OutstandingWarrants
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Payroll, Marketing And Sales Related Expenses
Other Marketing And Sales
Payroll,General And Administrative Related Expenses
Travel and Entertainment Expense
Operating Leases, Rent Expense
Other General and Administrative Expense
Other Financial Expense Income Net
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
Subcontracted Work And Consulting And Related Parties
Transactions And Balances With Interest Related Parties
Accounts Payable, Related Parties